Skip to main content
Global Spine Journal logoLink to Global Spine Journal
. 2025 Jul 9;15(3 Suppl):61S–74S. doi: 10.1177/21925682241289899

Osteoporosis in Adult Patients Undergoing Spinal Reconstructive Surgery: Associated Complications and Management

Zeeshan Sardar 1,✉, Josephine Coury 1, David Polly 2, Kenneth Cheung 3, Stephen J Lewis 4; AO Spine Knowledge Forum Deformity
Editors: Stephen J Lewis, Lawrence G Lenke
PMCID: PMC12254615  PMID: 40632286

Abstract

Study Design

Literature review.

Objectives

To provide an overview of the complications associated with and management strategies for adult patients with osteoporosis requiring spinal reconstructive surgery. Emphasis will be placed on screening, diagnosis, and perioperative medical and surgical management of these patients.

Methods

A review of the literature was performed for studies examining osteoporosis in adult patients undergoing spine surgery, associated complications, treatment and prevention methodologies.

Results

The reported incidence of osteoporosis in adult patients undergoing spinal reconstructive surgery was found to be 10% - 50%, whereas the incidence of osteopenia was 41.4% – 58.6%. DEXA scan is the most widely used modality for assessing bone mineral density (BMD) despite its limitations. Quantitative CT has been found to be the most optimal method for measuring BMD in the spine, yet, its availability is limited. Opportunistic CT scan-based Hounsfield Units (CTHU) have been found to correlate with osteoporosis and osteopenia, instrumentation loosening, proximal and distal junctional kyphosis, and pseudarthrosis. Patients treated with Teriparatide preoperatively and postoperatively were found to have a decreased rate of pseudarthrosis, screw loosening, and reoperation. Modifying surgical techniques can also improve outcomes. Such strategies could involve vertebral cement augmentation, iliac fixation in long constructs to the sacrum, and utilizing longer constructs when addressing spinal deformity or spinal instability.

Conclusions

The incidence of osteoporosis in patients undergoing spinal reconstruction is high. Appropriate preoperative and postoperative medical treatment can result in lower rates of adverse events related to osteoporosis. Surgical treatment and fixation can also be modified to account for suboptimal bone health.

Keywords: Osteoporosis, osteopenia, kyphosis, pseudarthrosis, vertebral body fracture, adult spinal deformity

Introduction

Multilevel spinal reconstructive surgery including instrumentation and fusion is often performed for surgical treatment of various spinal conditions including traumatic injuries, neoplasms, degenerative spinal conditions, and spinal deformity in an adult patient.1,2 The incidence of osteoporosis is high in the adult patients undergoing spinal reconstructive surgery (APUSRS).3,4 The incidence of unrecognized osteoporosis in this patient population is also high; up to 64% of patients being unaware of their osteoporosis diagnosis prior to spine surgery. 4 However, poor bone health can lead to severe complications for adult patients undergoing spinal reconstructive surgery.5-14

With recent evidence suggesting the benefits of osteoporosis treatment prior to surgery, it is essential for spine surgeons to understand how to screen for, diagnose, and treat osteoporosis prior to surgery.15,16

A review of the literature was performed for studies examining the incidence of osteoporosis in adult patients undergoing spine surgery, associated complications, treatment and prevention methodologies, as well as the awareness of this condition amongst spine surgeons. We discuss screening guidelines, diagnostic modalities, perioperative medical treatment, and surgical treatment strategies to decrease the risk of complications associated with osteoporosis in adult patients undergoing spinal reconstructive surgery.

Prevalence of Osteopenia/Osteoporosis in Adult Patients Undergoing Spinal Reconstructive Surgery

The prevalence of osteoporosis and osteopenia in a cohort of adult patients older than 50 undergoing spinal surgery was reported to be up to 60.6% in males and 92.7% in females. 17 Out of this cohort of 759 patients, 68% had a Dual-energy X-ray absorptiometry (DEXA) scan. Male patients had a 46.1% prevalence of osteopenia and 14.5% osteoporosis, whereas, females patients had a 41.4% prevalence of osteopenia and 51.3% osteoporosis based on the World Health Organization (WHO) criteria for osteoporosis. 17 Therefore, 60.6% of males and 92.7% of females over 50 undergoing spinal surgery had an abnormal bone mineral density (BMD) thus suggesting that patients over the age of 50 should have evaluation for osteopenia/osteoporosis prior to spine surgery.

In another cohort of 140 adult patients undergoing spinal fusion who had a DEXA scan within a year of their surgery, a 58.6% prevalence of osteopenia and 10% prevalence of osteoporosis was reported. 5

A recent systematic review of literature including 10 studies of patients over the age of 50 undergoing spinal surgery found the prevalence of osteoporosis to be 34.2%, whereas, the prevalence of osteopenia was 43.5%. 18 Therefore, up to 78.7% of patients undergoing spinal surgery had either osteopenia or osteoporosis. 18 The prevalence of osteoporosis increased significantly over the age of 60 in females. 18 A retrospective review of 124 candidates for spine surgery over the age of 50 found that the prevalence of osteoporosis was 45% in females and 20% in men and there was no significant difference in their T-scores. 19 These studies support screening for both male and female patients as opposed to disproportionately directing towards female patients only. 20

Attitudes towards Screening for Osteoporosis and Guidelines for Osteoporosis Screening in Adult Patients Undergoing Spinal Reconstructive Surgery

Complications related to poor bone health could potentially be decreased by preoperatively identifying osteoporosis or osteopenia and subsequently optimizing a patient’s bone health prior to surgery. Unfortunately, up to 64% of patients with osteoporosis have been found to be undiagnosed prior to spine surgery. 4 Several surveys of spine surgeons have been conducted in the past to understand their attitudes towards screening, diagnosing, and treating osteoporosis prior to spine surgery.21-23 The AO Spine Latin America conducted a survey of 349 spine surgeons and found that preoperative screening for osteoporosis was only performed by 19% of surgeons, however, this increased to 75% if the patient was thought to have a risk factor for osteoporosis. 21 The Spanish Neurosurgery Society’s (SENEC) survey of 77 memebrs showed that 32.5% of members do not consider formal evaluation of bone health even in patients with suspected Osteoporosis prior to spinal fusion and 37.7% do not consider medical treatment prior to surgery even in patients they suspect of having osteoporosis. 22 Another survey of 93 surgeons who attended a spine conference in Canada in 2007 reported that only 44% of participants obtained DEXA scans prior to instrumented spinal fusion and only 22% felt the need to obtain DEXA scan prior to un-instrumented spinal fusion. 23 They did not note a difference amongst practices between Neurosurgeons and Orthopedic surgeons and those in academic practice vs those in private practice. Additionally, only 19% reported routinely obtaining a DEXA scan as part of pseudarthrosis workup. 23 Even in patients being treated for a vertebral compression fracture, only 60% routinely obtained a DEXA scan. 23

In a study focused on assessing risk factors for acute fractures at the top of a long segmental fusion, only 39% of all patients were found to have BMD data available and only 54% of those with a fracture had BMD data. 13 These studies indicate that poor bone health is frequently underdiagnosed and emphasizes the need for better preoperative screening.

The 2019 International Society for Clinical Densitometry (ISCD) Official Positions on Use of Bone Health Evaluation in Orthopedic Surgery concluded that all adult patients undergoing elective orthopedic or spine surgery should undergo a bone health evaluation. 24

The ISCD and the National Osteoporosis Foundation (NOF) suggest that BMD testing should be performed in men over the age of 70 and women over the age of 65. 24 For those younger than the suggested age, BMD testing is required if they have certain risk factors for development of osteoporosis. The ISCD 2019 position agreed on the following risk factors: diabetes mellitus, inflammatory arthritis, chronic corticosteroids (5 mg per day for 3 or more months of treatment), a low-trauma fracture after 50 years of age, limited mobility, smoking, and chronic kidney disease stage 3, 4, and 5. 24

The Fracture Risk Assessment Tool (FRAX) can be used to estimate a patient’s 10-year probability of a hip or major osteoporotic fracture including the spine. 25 FRAX includes the following risk factors for elevated fracture probability: age, fracture after the age of 50, parental history of hip fracture, current smoking, chronic corticosteroids, rheumatoid arthritis, and alcohol use >3 units per day.25,26 Finally, the NOF criteria too includes adults with a history of fracture after age 50. 27

Recently, through a Delphi method involving spine surgeons and bone health specialists, a set of guidelines was published for the assessment and treatment of patients with osteoporosis undergoing spine surgery. 28 They recommended BMD testing for all patients over the age of 65 prior to spinal reconstructive surgery and for those above age 50 with one of the aforementioned risk factors.

Diagnostic Modalities for Assessment of Bone Health

Patients in need of formal assessment of bone health are usually referred for a DEXA scan which is considered the current gold standard for bone health evaluation (Figure 1).29,30 DEXA scans are widely used to diagnose and guide medical treatment of osteoporosis. 30 The ISCD 2019 official position recommends that hip and spine DEXA scan should be obtained in these cases. 24

Figure 1.

Figure 1.

Example of a DEXA of the hip and lumbar spine.

The DEXA scan of the spine can have several limitations.30,31 BMD of the spine measured by DEXA can be inaccurate in patients with scoliosis due to overlap of vertebral segments.30,31 The presence of significant osteophytes can spuriously elevate the measured BMD in the spine.30,31 BMD of the spine is difficult to measure in the presence of spinal fusion or spinal instrumentation. Therefore, a hip DEXA is usually recommended in addition to a spine DEXA. However, in the presence of hip implants and unreliable spine BMD from DEXA, opportunistic assessment by CT or QCT can be a better alternative. 30

Measurement of CT based Hounsfield units (CTHU) was described in 2011 as an opportunistic method of assessing bone health. 32 CT scans are often routinely performed prior to spinal instrumentation procedure, therefore, the use of this opportunistic method of bone health assessment has gained popularity. This involves measuring CTHUs on 3 different axial slices through a vertebral body (superior, middle, inferior) and using their mean (Figure 2). CTHU measurement is typically performed at lumbar segments L1-4 and has been found to correlate with DEXA scan-based BMD in multiple studies.4,7,14,32-38 CTHU has also been shown to have high sensitivity (0.73) and positive predictive value (0.85) in diagnosing osteoporosis when compared to DEXA scans. 32 Therefore, opportunistic CT-based attenuation using HUs can be used to estimate the likelihood of osteoporosis with the parameter of L1 CTHU <100 as abnormal and L1 CTHU >150 as normal to support decisions regarding bone health assessment. 24

Figure 2.

Figure 2.

Demonstration of measuring Hounsfield Units on CT scan. A: Mid sagittal cut of a Lumbar CT with the green lines in L3 showing the Axial cuts; B: Axial cut just below the superior end plate. C: Axial cut in the middle of the body. D: Axial cut just above the superior end plate.

Wagner et al. 4 demonstrated the efficacy of opportunistic CTHU by finding that 49.2% of all patients older than age 50 undergoing TLIF had evidence of decreased BMD on CTHU, with 19.5% consistent with osteoporosis and 29.7% consistent with osteopenia. Only 36% of the patients with osteopenia and osteoporosis on CTHU had DEXA scans and only 23.7% of the osteopenic group had been prescribed medications to improve BMD. 4 Several studies also identified that lower CTHU values in the lumbar spine were associated with vertebral fracture and adjacent segment fractures.7,34 Schreiber et al found that patients with a successful fusion had significantly higher CTHU values of 203.3 vs 139.8 for those with pseudarthrosis. 14 Other studies have found an association between cage subsidence and low CTHUs.39,40 Meredith reported that patients who developed adjacent segment fracture after undergoing spinal fusion had a lower CTHU value compared to those without a fracture (145.6 vs 199.4). 7 Overall, these studies suggest the utility of using CTHU on opportunistic CTs when a formal DEXA is not available.

Quantitative computed tomography (QCT) is another imaging modality used to assess BMD. QCT offers a volumetric analysis of trabecular bone mineral density which has been shown to be more precise when compared to DEXA scan. A QCT measurement of BMD <90 mg/mL is shown to have an increased risk of pedicle screw loosening as opposed to >120 mg/mL. 41 However, its limited availability, higher cost, and increased radiation prevent QCT from being used as a standardized screening and diagnostic tool.

Another opportunistic method of assessing bone health of the spine is the Biomechanical Computed Tomography analysis (BCT).42-48 BCT performs a measure of the vertebral body strength using finite element analysis (FEA) and also measures the vertebral trabecular BMD.46,47 BCT has been reported to predict the risk of vertebral body fracture independent of the BMD. 46 In a recent retrospective observational cohort, patients who tested positive for osteoporosis using BCT were found to have a 5 times higher risk of vertebral fractures after undergoing spinal fusion and had an up to 4 times risk of reoperation. 47

Due to the wide availability of DEXA scans, the guidelines published in 2022 recommend Hip and Spine DEXA scan for diagnosing osteoporosis along with a vertebral fracture assessment. 28 They recommend using the Z score for patients aged 20 to 50 and T score for patients older than 50. 28 Finally, they recommend using CTHU for opportunistic screening if a DEXA is not available. 28

Adverse Events Related to Osteoporosis

Osteoporosis is linked to several complications in APUSRS such as vertebral fractures (Figure 4), instrumentation failure, pseudarthrosis, proximal or distal junctional kyphosis (PJK/DJK), and unplanned reoperation (Figure 3).5-14 Patients with osteoporosis and osteopenia are at a 2 times higher risk for pseudarthrosis and 3 or more times higher risk for revision surgery compared to those with normal bone density likely due to deficient or inadequate mechanical support from the instrumentation.5,10-12 Osteopenia, however, has not been found to be a risk factor for pseudarthrosis. 5

Figure 4.

Figure 4.

X-rays (A) and CT scan (B) of a patient with multiple osteoporosis related fractures at L1, L2, L4. Retropulsed fragment into the canal can be seen at L1 causing severe stenosis.

Figure 3.

Figure 3.

CT scan of a patient with osteoporosis with sacral fracture and bilateral S1 screw loosening after instrumentation from L4-S1.

Low BMD is considered a risk factor for the development of PJK (Figure 5).8,9,49,50 Patients with osteoporosis are estimated to have up to 2-times the risk of PJK compared to patients with normal BMD.8,9 The average T score was found to be significantly lower in patients with fracture at the top of the construct as opposed to those without a fracture (−1.73 vs −0.58) in patients who had undergone surgery for adult spinal deformity. 13 Osteoporosis and low bone mineral density (BMD) are more likely to occur in older patients, and as such have been a commonly reported risk factor for the development of PJK.51-53 However, PJK is related to multiple factors, therefore, a few other studies failed to identify osteoporosis as an independent risk factor for PJK.9,51,54

Figure 5.

Figure 5.

A patient with compression fracture at the Upper Instrumented Segment leading to Proximal Junctional Kyphosis.

Medical Treatment of Osteoporosis Prior to Surgery

Osteoporosis remains underdiagnosed and undertreated prior to spine surgery.12,19,55 Patients should be appropriate screened for osteoporosis prior to spine surgery and should receive medical treatment for the osteoporosis prior to spine surgery. 24 This treatment is often guided by a bone health specialist such as an endocrinologist or rheumatologist. 24 A review of 849 patients with osteoporosis undergoing spinal fusion found that only 14.3% of patients received medical treatment for osteoporosis prior to surgery and 43% of those patients had ongoing prescriptions for medical management of osteoporosis at 1 year after surgery. 55 Another study reported that only 27% of patients with a diagnosis of osteoporosis and 10% of patients with osteopenia were using medications for treatment of bone health. 12 Amongst the few on medications, bisphosphonates were the most commonly utilized medications accounting for 95%–98.8%. 12

Some facilities have developed a service to formally evaluate patients for osteoporosis prior to spine surgery. 19 In a review of 124 patients above age 50 who were candidates for joint arthroplasty or spine surgery, 91% were found to meet the national osteoporosis foundation (NOF) criteria for requiring medical treatment for osteoporosis. 19 On the other hand, most spine surgeons may prefer to have their patients referred to other bone health specialists, such as endocrinologists or rheumatologists, for medical treatment of osteoporosis. 21

Multiple studies have reported on the benefits of medical treatment for osteoporosis prior to spine surgery.55-57 The patients who underwent osteoporosis treatment prior to surgery have been reported to have a significantly lower rate of complications and revision surgery compared to those who have not been treated. 55 This study and others indicate the potential benefit of osteoporosis treatment in spine surgery, specifically by anabolic medications, and the need for additional studies.56,57

Teriparatide, a parathyroid hormone analog, has been studied in the context of spine surgery. Its anabolic mechanism suggests it may promote fusion after surgery, unlike bisphosphonates (BPs), which primarily help maintain bone mass.58-61

Medical treatment with Teriparatide perioperatively has been shown to result in a decrease in complication rates including screw loosening, rod fracture, adjacent vertebral fracture, and pseudarthrosis when compared to bisphosphonates or no treatment.57,59,62-64 Four studies identified a shorter time to bone union and 4 studies identified a higher overall rate of fusion with TP as compared to BPs or no medical treatment.58-61,65,66 Inoue et al. 67 uniquely studied insertional torque of pedicle screws for patients treated preoperatively with TP for 1 month and found a higher insertional torque as compared to patients with no medical treatment. Recently, a retrospective study reported on the benefits of medical management with TP prior to long segment posterior spinal fusion defined as 8 or more levels. 16 The study compared patients with osteoporosis treated with TP against those with Osteopenia and those with normal BMD. 16 Interestingly, patients with osteoporosis treated with TP had better patient reported outcomes and lower reoperation and symptomatic pseudarthrosis rate compared to those with osteopenia. 16 Whereas, the outcomes of those with osteoporosis treated with TP were equivalent to patients with normal BMD. 16

Studies with short term use of TP postoperatively have not found a benefit of TP on fusion rate or instrumentation complications.68,69 These studies suggest that longer than 6 months of postoperative dosing is likely required, as was done in the other studies which found a significant difference in patients receiving TP post operatively. TP was well tolerated in all studies, with primarily nausea, anorexia, and fatigue cited as side effects in two studies.59,65

Abaloparatide is an isolated human parathyroid hormone that is also an anabolic, bone forming medication. The effectiveness of Abaloparatide in improving BMD and decreasing vertebral fractures has been proven in many studies.70-73 Abaloparatide is considered an alternative to teriparatide due to its similar mechanism of action. However, at present, there is no available literature on the use of Abaloparatide in spine surgery.

Bisphosphonates are the most common medications used in treating osteoporosis. 21 There are multiple studies regarding the efficacy and safety profile of bisphosphonates in spine surgery.74-82 Alendronate was shown to improve fusion rates after spine surgery in 2 studies and decreased the incidence of cage subsidence and vertebral fracture in one.74,75 One study demonstrated no effect of alendronate on fusion rate. 76 Zoledronate was shown to shorten the time to fusion and improve fusion rate in 3 studies, and to decrease the incidence of complications including cage subsidence, pedicle screw loosening, and vertebral compression fracture.77-79,82 However, another 3 studies found that zoledronate did not affect fusion rate.80-82 No study thus far has shown a negative effect of bisphosphonate use on fusion in spine surgery. However, several studies have demonstrated a superior outcome with Teriparatide use in spinal fusion when compared directly to bisphosphonates.59-62,64,66,69,83

Denosumab is similar to bisphosphonates in that it works as an antiresorptive medication. One study of denosumab in spine surgery exists where denosumab is combined with teriparatide (n = 9) and compared to teriparatide alone (n = 9), finding that the combination group had a higher lumbar interbody fusion rate and femoral neck BMD at 6 months. 84 Aside from this study, the effectiveness of denosumab in preventing vertebral compression fractures and other osteoporotic fractures has been well demonstrated in the Freedom Trial. 85

Romosozumab, a monoclonal anti-sclerostin antibody, is a newer medication that has both anabolic and antiresorptive effects.31,86-88 Mikula et al. 88 reported that treatment with Romosozumab for a mean duration of 10.5 months in 32 patients with osteoporosis resulted in a mean lumbar spine (L1-L4) CTHU improvement of 26% from baseline. It has not been specifically studied in spine surgery, however, its efficacy in preventing vertebral compression fractures has been well studied as it has been shown to decrease new vertebral fractures by 73% at 12 months.86,87

The guidelines by Sardar et al. 28 recommend using Teriparatide or Abaloparatide as the first line agent for the treatment of osteoporosis in adult patients planning to undergo spinal reconstruction. Antiresorptive agents such as Denosumab or Zoledronate are recommended if there are contraindications to the use of anabolic agents or if the patients are unable to tolerate the anabolic agents. 28

Optimizing Vitamin D and Calcium Levels Prior to Surgery

Vitamin D deficiency is commonly seen in patients undergoing spinal surgery and is often not diagnosed prior to the surgery.89-91 Assessment and treatment of low serum 25-hydroxyvitamin D levels is important prior to spine surgery and is an important component of the medical treatment of osteoporosis. Panjoka et al found that surgeons requested serum calcium levels in 67% of cases and vitamin D levels in 59% of patients. 21 The literature regarding vitamin D deficiency in spine surgery is limited. Several studies have demonstrated that higher vitamin D levels are linked to improved clinical outcomes, including better ODI scores and reduced pain after spine surgery.91-94 Ravindra et al found a statistically significant association between vitamin D deficiency and both nonunion and longer time to fusion within the first year following spinal fusion surgery. In contrast, Donnally et al. 95 reported no significant differences in spinal fusion rates, revision surgeries, or instrumentation failure after one year. Vitamin D supplementation is suggested for those with Vitamin D insufficiency.28,93,96

Fixation Strategies in Osteoporotic Bone

Multiple techniques to improve fixation in the osteoporotic spine have been developed. These include sublaminar wiring, cement augmentation of pedicle screw fixation (Figure 6), hook fixation, conical screws, hydroxyapatite-coated screws, fenestrated screws, expandable screws, and circumferential fusion (Figure 6).10,97,98 Other techniques employed to improve fixation in osteoporotic bone include using pedicle screws of larger diameter and length, limited tapping of the pedicle, achieving bicortical fixation, and creating a longer instrumented spinal construct.41,97,98

Figure 6.

Figure 6.

Example of Cement augmentation and anterior column support to improve fixation in patients with Osteoporosis.

Iliac or pelvic fixation is important in patients with osteoporosis if a multisegmented fusion to the sacrum is being planned.98,99 This can avoid subsequent S1 screw loosening or sacral fractures which can be seen in patients with osteoporosis undergoing spinal fusions to the sacrum (Figure 3).98-101

Cement augmentation of the vertebral bodies at UIV and UIV +1 has been studied in the context of decreasing proximal junctional kyphosis in patients with osteopenia or osteoporosis.102-104 Findings support a lower incidence of early junctional failure and junctional kyphosis within 6 months of surgery with cement augmentation of both UIV and UIV +1 as opposed to no cement augmentation or cement augmentation of only the UIV.102-104 The UIV in these studies was in the lower thoracic spine.102-104 Unfortunately, a 5 year follow up study did not show a significant difference in PJK or PJF rates. 105

A survey of Spanish surgeons concluded that only 48% of members modified their surgical strategy in patients with osteoporosis and 70% of those would choose cement augmentation of the pedicle screws as their preferred technique (Figure 6). 22

A survey of 349 surgeons belonging to AO Spine Latin America reported that when treating patients with osteoporosis, 65.3% of surgeons extended instrumentation to incorporate additional levels and 63.8% utilized cement augmentation of vertebral bodies. 21 However, only 21% of surgeons believed that osteoporosis was the main cause of a poor final surgical outcome.

Circumferential fusion is another strategy noted to be employed for fusion in patients with osteoporosis. In a nationwide inpatient sample of patients undergoing cervical spine surgery from 2002 to 2011, Osteoporotic patients were more than 2 times likely to undergo posterior cervical spine fusion and 3 times more likely to undergo combined anterior/posterior fusion compared to those without osteoporosis. 10

Management of patients with osteoporotic vertebral fractures leading to sagittal plane deformities is not very well defined. Anterior reconstruction with strut graft or a cage has been shown to be effective in managing osteoporotic fractures with kyphosis. 106 For patients with severe kyphotic deformity and neurologic compromise, posterior closing wedge osteotomy has demonstrated better outcomes compared to combined anterior-posterior procedure with a lower blood loss and shorter operative time. 107

Summary

The incidence of osteoporosis in patients undergoing spinal reconstruction is significant and is reported between 10%-50%. Bone mineral density testing (BMD) using a DEXA scan is recommended for all patients over the age of 65 planning to undergo ASD surgery. Those younger than 65 with a risk factor should also undergo BMD testing. Such risk factors include: previous low energy fracture, history of metabolic bone disease, chronic corticosteroid use, smoking, excessive alcohol use, chronic kidney disease, prior failed surgery (fracture, pseudarthrosis, instrumentation failure), history of cancer treatment, chronic kidney disease, active smoker. Opportunistic CT based Hounsfield units can be used to get an estimate of the patient’s bone health and can lead to formal assessment in those with low CTHU values. Patients who qualify for medical treatment of osteoporosis prior to surgery should receive medical treatment for optimization prior to surgery. The duration of treatment may depend on the type of agent used. Anabolic agents such as Teriparatide and Abaloparatide can decrease the risk of osteoporosis related complications such as instrumentation loosening, proximal junctional kyphosis, and pseudarthrosis if used for the appropriate period before and after ASD surgery.

Techniques to improve fixation in the osteoporotic spine include sublaminar wiring, cement augmentation of pedicle screw fixation, hook fixation, conical screws, hydroxyapatite-coated screws, expandable screws, and circumferential fusion. Screw fixation can be further optimized by using pedicle screws of larger diameter and length, limiting tapping of the pedicle, and achieving bicortical fixation. Iliac or Pelvic fixation should be strongly considered in patient osteoporosis undergoing a long segment fusion to the sacrum.

Future Directions and Research

Future directions should involve studying the optimal duration of preop and postop treatment with anabolic agents such as Teriparatide. Further research is also needed to establish thresholds for bone mineral density that would lead to adverse outcomes in patients undergoing spinal reconstruction. Additionally, new bone mineral density thresholds need to be identified to trigger medical treatment of patient with osteopenia due to the non-physiologic stress placed on vertebra after spinal reconstruction even if they don’t meet the WHO definition for osteoporosis.

Footnotes

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This supplement was organized and financially supported by AO Spine through the AO Spine Knowledge Forum Deformity, a focused group of international Adult Spinal Deformity experts. AO Spine is a clinical division of the AO Foundation, which is an independent medically-guided not-for-profit organization. Support was provided directly through AO Network Clinical Research.

ORCID iDs

Zeeshan Sardar https://orcid.org/0000-0002-8417-3798

Josephine Coury https://orcid.org/0000-0002-4511-1172

David Polly https://orcid.org/0000-0001-7572-6584

Kenneth Cheung https://orcid.org/0000-0001-8304-0419

Stephen J. Lewis https://orcid.org/0000-0002-9173-8443

References

  • 1.Reisener MJ, Pumberger M, Shue J, Girardi FP, Hughes AP. Trends in lumbar spinal fusion-a literature review. J Spine Surg. 2020;6(4):752-761. doi: 10.21037/jss-20-492 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Martin BI, Mirza SK, Spina N, Spiker WR, Lawrence B, Brodke DS. Trends in lumbar fusion procedure rates and associated hospital costs for degenerative spinal diseases in the United States, 2004 to 2015. Spine. 2019;44(5):369-376. doi: 10.1097/BRS.0000000000002822 [DOI] [PubMed] [Google Scholar]
  • 3.Fan ZQ, Yan XA, Li BF, et al. Prevalence of osteoporosis in spinal surgery patients older than 50 years: a systematic review and meta-analysis. PLoS One. 2023;18(5):e0286110. doi: 10.1371/journal.pone.0286110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wagner SC, Formby PM, Helgeson MD, Kang DG. Diagnosing the undiagnosed: osteoporosis in patients undergoing lumbar fusion. Spine. 2016;41(21):E1279-E1283. doi: 10.1097/BRS.0000000000001612 [DOI] [PubMed] [Google Scholar]
  • 5.Bjerke BT, Zarrabian M, Aleem IS, et al. Incidence of osteoporosis-related complications following posterior lumbar fusion. Global Spine J. 2018;8(6):563-569. doi: 10.1177/2192568217743727 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.DeWald CJ, Stanley T. Instrumentation-related complications of multilevel fusions for adult spinal deformity patients over age 65: surgical considerations and treatment options in patients with poor bone quality. Spine. 2006;31(19):S144-S151. doi: 10.1097/01.brs.0000236893.65878.39 [DOI] [PubMed] [Google Scholar]
  • 7.Meredith DS, Schreiber JJ, Taher F, Cammisa FP, Jr., Girardi FP. Lower preoperative Hounsfield unit measurements are associated with adjacent segment fracture after spinal fusion. Spine. 2013;38(5):415-418. doi: 10.1097/BRS.0b013e31826ff084 [DOI] [PubMed] [Google Scholar]
  • 8.Kim JS, Phan K, Cheung ZB, et al. Surgical, radiographic, and patient-related risk factors for proximal junctional kyphosis: a meta-analysis. Global Spine J. 2019;9(1):32-40. doi: 10.1177/2192568218761362 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hyun SJ, Kim YJ, Rhim SC. Patients with proximal junctional kyphosis after stopping at thoracolumbar junction have lower muscularity, fatty degeneration at the thoracolumbar area. Spine J. 2016;16(9):1095-1101. doi: 10.1016/j.spinee.2016.05.008 [DOI] [PubMed] [Google Scholar]
  • 10.Guzman JZ, Feldman ZM, McAnany S, Hecht AC, Qureshi SA, Cho SK. Osteoporosis in cervical spine surgery. Spine. 2016;41(8):662-668. doi: 10.1097/BRS.0000000000001347 [DOI] [PubMed] [Google Scholar]
  • 11.Gupta A, Cha T, Schwab J, et al. Osteoporosis increases the likelihood of revision surgery following a long spinal fusion for adult spinal deformity. Spine J. 2021;21(1):134-140. doi: 10.1016/j.spinee.2020.08.002 [DOI] [PubMed] [Google Scholar]
  • 12.Khalid SI, Nunna RS, Maasarani S, et al. Association of osteopenia and osteoporosis with higher rates of pseudarthrosis and revision surgery in adult patients undergoing single-level lumbar fusion. Neurosurg Focus. 2020;49(2):E6. doi: 10.3171/2020.5.FOCUS20289 [DOI] [PubMed] [Google Scholar]
  • 13.O'Leary PT, Bridwell KH, Lenke LG, et al. Risk factors and outcomes for catastrophic failures at the top of long pedicle screw constructs: a matched cohort analysis performed at a single center. Spine. 2009;34(20):2134-2139. doi: 10.1097/BRS.0b013e3181b2e17e [DOI] [PubMed] [Google Scholar]
  • 14.Schreiber JJ, Hughes AP, Taher F, Girardi FP. An association can be found between hounsfield units and success of lumbar spine fusion. HSS J. 2014;10(1):25-29. doi: 10.1007/s11420-013-9367-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Jain N, Labaran L, Phillips FM, et al. Prevalence of osteoporosis treatment and its effect on post-operative complications, revision surgery and costs after multi-level spinal fusion. Global Spine J. 2022;12(6):1119-1124. doi: 10.1177/2192568220976560 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Mohanty S, Sardar ZM, Hassan FM, Lombardi JM, Lehman RA, Lenke LG. Impact of teriparatide on complications and patient-reported outcomes of patients undergoing long spinal fusion according to bone density. J Bone Joint Surg Am. 2024;106(3):206-217. doi: 10.2106/JBJS.23.00272 [DOI] [PubMed] [Google Scholar]
  • 17.Chin DK, Park JY, Yoon YS, et al. Prevalence of osteoporosis in patients requiring spine surgery: incidence and significance of osteoporosis in spine disease. Osteoporos Int. 2007;18(9):1219-1224. doi: 10.1007/s00198-007-0370-8 [DOI] [PubMed] [Google Scholar]
  • 18.Fan ZQ, Yan XA, Li BF, et al. Prevalence of osteoporosis in spinal surgery patients older than 50 years: a systematic review and meta-analysis. PLoS One. 2023;18(5):e0286110. doi: 10.1371/journal.pone.0286110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Kadri A, Binkley N, Hare KJ, Anderson PA. Bone health optimization in orthopaedic surgery. J Bone Joint Surg Am. 2020;102(7):574-581. doi: 10.2106/JBJS.19.00999 [DOI] [PubMed] [Google Scholar]
  • 20.Kuprys TK, Steinmetz LM, Fischer CR, et al. Preoperative assessment of bone quality in spine deformity surgery: correlation with clinical practice and published recommendations. Spine. 2019;44(12):E735-E741. doi: 10.1097/BRS.0000000000002956 [DOI] [PubMed] [Google Scholar]
  • 21.Pantoja S, Molina M. Surgeon management of osteoporosis in instrumented spine surgery: AOSpine Latin America survey. Global Spine J. 2019;9(2):169-172. doi: 10.1177/2192568218785369 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Diaz-Romero Paz R, Sosa Henriquez M, Armas Melian K, Coloma Valverde G. Trends and attitudes of spine surgeons regarding osteoporosis. Neurocirugia (Astur). 2019;30(6):268-277. doi: 10.1016/j.neucir.2019.04.004 [DOI] [PubMed] [Google Scholar]
  • 23.Dipaola CP, Bible JE, Biswas D, Dipaola M, Grauer JN, Rechtine GR. Survey of spine surgeons on attitudes regarding osteoporosis and osteomalacia screening and treatment for fractures, fusion surgery, and pseudoarthrosis. Spine J. 2009;9(7):537-544. doi: 10.1016/j.spinee.2009.02.005 [DOI] [PubMed] [Google Scholar]
  • 24.Anderson PA, Morgan SL, Krueger D, et al. Use of bone health evaluation in orthopedic surgery: 2019 ISCD official position. J Clin Densitom. 2019;22(4):517-543. doi: 10.1016/j.jocd.2019.07.013 [DOI] [PubMed] [Google Scholar]
  • 25.Kanis JA, Harvey NC, Cooper C, et al. A systematic review of intervention thresholds based on FRAX : a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporosis. 2016;11(1):25. doi: 10.1007/s11657-016-0278-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Watts NB. The Fracture Risk Assessment Tool (FRAX®): applications in clinical practice. J Womens Health (Larchmt) 2011;20(4):525-531. [DOI] [PubMed] [Google Scholar]
  • 27.LeBoff MS, Greenspan SL, Insogna KL, et al. The clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022;33(10):2049-2102. doi: 10.1007/s00198-021-05900-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Sardar ZM, Coury JR, Cerpa M, et al. Best practice guidelines for assessment and management of osteoporosis in adult patients undergoing elective spinal reconstruction. Spine. 2022;47(2):128-135. doi: 10.1097/BRS.0000000000004268 [DOI] [PubMed] [Google Scholar]
  • 29.Carlson BC, Robinson WA, Wanderman NR, et al. A review and clinical perspective of the impact of osteoporosis on the spine. Geriatr Orthop Surg Rehabil. 2019;10. doi: 10.1177/2151459319861591 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Deshpande N, Hadi MS, Lillard JC, et al. Alternatives to DEXA for the assessment of bone density: a systematic review of the literature and future recommendations. J Neurosurg Spine. 2023;38(4):436-445. doi: 10.3171/2022.11.SPINE22875 [DOI] [PubMed] [Google Scholar]
  • 31.Anderson PA, Binkley NC, Bernatz JT. Bone health optimization (BHO) in spine surgery. Spine. 2023;48(11):782-790. doi: 10.1097/BRS.0000000000004618 [DOI] [PubMed] [Google Scholar]
  • 32.Schreiber JJ, Anderson PA, Rosas HG, Buchholz AL, Au AG. Hounsfield units for assessing bone mineral density and strength: a tool for osteoporosis management. J Bone Joint Surg Am. 2011;93(11):1057-1063. doi: 10.2106/JBJS.J.00160 [DOI] [PubMed] [Google Scholar]
  • 33.Bredow J, Boese CK, Werner CM, et al. Predictive validity of preoperative CT scans and the risk of pedicle screw loosening in spinal surgery. Arch Orthop Trauma Surg. 2016;136(8):1063-1067. doi: 10.1007/s00402-016-2487-8 [DOI] [PubMed] [Google Scholar]
  • 34.Buckens CF, Dijkhuis G, de Keizer B, Verhaar HJ, de Jong PA. Opportunistic screening for osteoporosis on routine computed tomography? An external validation study. Eur Radiol. 2015;25(7):2074-2079. doi: 10.1007/s00330-014-3584-0 [DOI] [PubMed] [Google Scholar]
  • 35.Choi MK, Kim SM, Lim JK. Diagnostic efficacy of Hounsfield units in spine CT for the assessment of real bone mineral density of degenerative spine: correlation study between T-scores determined by DEXA scan and Hounsfield units from CT. Acta Neurochir. 2016;158(7):1421-1427. doi: 10.1007/s00701-016-2821-5 [DOI] [PubMed] [Google Scholar]
  • 36.Pickhardt PJ, Pooler BD, Lauder T, del Rio AM, Bruce RJ, Binkley N. Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med. 2013;158(8):588-595. doi: 10.7326/0003-4819-158-8-201304160-00003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Lee S, Chung CK, Oh SH, Park SB. Correlation between bone mineral density measured by dual-energy X-ray absorptiometry and hounsfield units measured by diagnostic CT in lumbar spine. J Korean Neurosurg Soc. 2013;54(5):384-389. doi: 10.3340/jkns.2013.54.5.384 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Tay WL, Chui CK, Ong SH, Ng AC. Osteoporosis screening using areal bone mineral density estimation from diagnostic CT images. Acad Radiol. 2012;19(10):1273-1282. doi: 10.1016/j.acra.2012.05.017 [DOI] [PubMed] [Google Scholar]
  • 39.Mi J, Li K, Zhao X, Zhao CQ, Li H, Zhao J. Vertebral body hounsfield units are associated with cage subsidence after transforaminal lumbar interbody fusion with unilateral pedicle screw fixation. Clin Spine Surg. 2017;30(8):E1130-E1136. doi: 10.1097/BSD.0000000000000490 [DOI] [PubMed] [Google Scholar]
  • 40.Ullrich BW, Schenk P, Spiegl UJ, Mendel T, Hofmann GO. Hounsfield units as predictor for cage subsidence and loss of reduction: following posterior-anterior stabilization in thoracolumbar spine fractures. Eur Spine J. 2018;27(12):3034-3042. doi: 10.1007/s00586-018-5792-9 [DOI] [PubMed] [Google Scholar]
  • 41.Fiani B, Newhouse A, Sarhadi KJ, Arshad M, Soula M, Cathel A. Special considerations to improve clinical outcomes in patients with osteoporosis undergoing spine surgery. Internet J Spine Surg. 2021;15(2):386-401. doi: 10.14444/8050 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Adams AL, Fischer H, Kopperdahl DL, et al. Osteoporosis and hip fracture risk from routine computed tomography scans: the fracture, osteoporosis, and CT utilization study (FOCUS). J Bone Miner Res. 2018;33(7):1291-1301. doi: 10.1002/jbmr.3423 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Izzy M, Addissie BD, Arab JP, et al. Triple-Phase computed tomography may replace dual-energy X-ray absorptiometry scan for evaluation of osteoporosis in liver transplant candidates. Liver Transplant. 2021;27(3):341-348. doi: 10.1002/lt.25926 [DOI] [PubMed] [Google Scholar]
  • 44.Weber NK, Fidler JL, Keaveny TM, et al. Validation of a CT-derived method for osteoporosis screening in IBD patients undergoing contrast-enhanced CT enterography. Am J Gastroenterol. 2014;109(3):401-408. doi: 10.1038/ajg.2013.478 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Burch S, Feldstein M, Hoffmann PF, Keaveny TM. Prevalence of poor bone quality in women undergoing spinal fusion using biomechanical-CT analysis. Spine. 2016;41(3):246-252. doi: 10.1097/BRS.0000000000001175 [DOI] [PubMed] [Google Scholar]
  • 46.Keaveny TM, Clarke BL, Cosman F, et al. Biomechanical Computed Tomography analysis (BCT) for clinical assessment of osteoporosis. Osteoporos Int. 2020;31(6):1025-1048. doi: 10.1007/s00198-020-05384-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Keaveny TM, Adams AL, Fischer H, et al. Increased risks of vertebral fracture and reoperation in primary spinal fusion patients who test positive for osteoporosis by Biomechanical Computed Tomography analysis. Spine J. 2023;23(3):412-424. doi: 10.1016/j.spinee.2022.10.018 [DOI] [PubMed] [Google Scholar]
  • 48.Fidler JL, Murthy NS, Khosla S, et al. Comprehensive assessment of osteoporosis and bone fragility with CT colonography. Radiology. 2016;278(1):172-180. doi: 10.1148/radiol.2015141984 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Yagi M, King AB, Boachie-Adjei O. Incidence, risk factors, and natural course of proximal junctional kyphosis: surgical outcomes review of adult idiopathic scoliosis. Minimum 5 years of follow-up. Spine. 2012;37(17):1479-1489. doi: 10.1097/BRS.0b013e31824e4888 [DOI] [PubMed] [Google Scholar]
  • 50.Kim YJ, Bridwell KH, Lenke LG, Rhim S, Kim YW. Is the T9, T11, or L1 the more reliable proximal level after adult lumbar or lumbosacral instrumented fusion to L5 or S1? Spine. 2007;32(24):2653-2661. doi: 10.1097/BRS.0b013e31815a5a9d [DOI] [PubMed] [Google Scholar]
  • 51.Kim HJ, Yagi M, Nyugen J, Cunningham ME, Boachie-Adjei O. Combined anterior-posterior surgery is the most important risk factor for developing proximal junctional kyphosis in idiopathic scoliosis. Clin Orthop Relat Res. 2012;470(6):1633-1639. doi: 10.1007/s11999-011-2179-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Kim HJ, Bridwell KH, Lenke LG, et al. Proximal junctional kyphosis results in inferior SRS pain subscores in adult deformity patients. Spine. 2013;38(11):896-901. doi: 10.1097/BRS.0b013e3182815b42 [DOI] [PubMed] [Google Scholar]
  • 53.Yagi M, Akilah KB, Boachie-Adjei O. Incidence, risk factors and classification of proximal junctional kyphosis: surgical outcomes review of adult idiopathic scoliosis. Spine. 2011;36(1):E60-E68. doi: 10.1097/BRS.0b013e3181eeaee2 [DOI] [PubMed] [Google Scholar]
  • 54.Maruo K, Ha Y, Inoue S, et al. Predictive factors for proximal junctional kyphosis in long fusions to the sacrum in adult spinal deformity. Spine. 2013;38(23):E1469-E1476. doi: 10.1097/BRS.0b013e3182a51d43 [DOI] [PubMed] [Google Scholar]
  • 55.Jain N, Labaran L, Phillips FM, et al. Prevalence of osteoporosis treatment and its effect on post-operative complications, revision surgery and costs after multi-level spinal fusion. Global Spine J. 2020;12:1119-1124. doi: 10.1177/2192568220976560 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Morris MT, Tarpada SP, Tabatabaie V, Cho W. Medical optimization of lumbar fusion in the osteoporotic patient. Arch Osteoporosis. 2018;13(1):26. doi: 10.1007/s11657-018-0427-7 [DOI] [PubMed] [Google Scholar]
  • 57.Buerba RA, Sharma A, Ziino C, Arzeno A, Ajiboye RM. Bisphosphonate and teriparatide use in thoracolumbar spinal fusion: a systematic review and meta-analysis of comparative studies. Spine. 2018;43(17):E1014-E1023. doi: 10.1097/BRS.0000000000002608 [DOI] [PubMed] [Google Scholar]
  • 58.Ushirozako H, Hasegawa T, Ebata S, et al. Weekly teriparatide administration and preoperative anterior slippage of the cranial vertebra next to fusion segment < 2 mm promote osseous union after posterior lumbar interbody fusion. Spine. 2019;44(5):E288-E297. doi: 10.1097/BRS.0000000000002833 [DOI] [PubMed] [Google Scholar]
  • 59.Seki S, Hirano N, Kawaguchi Y, et al. Teriparatide versus low-dose bisphosphonates before and after surgery for adult spinal deformity in female Japanese patients with osteoporosis. Eur Spine J. 2017;26(8):2121-2127. doi: 10.1007/s00586-017-4959-0 [DOI] [PubMed] [Google Scholar]
  • 60.Ohtori S, Orita S, Yamauchi K, et al. More than 6 Months of teriparatide treatment was more effective for bone union than shorter treatment following lumbar posterolateral fusion surgery. Asian Spine J. 2015;9(4):573-580. doi: 10.4184/asj.2015.9.4.573 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Ohtori S, Inoue G, Orita S, et al. Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study. Spine. 2012;37(23):E1464-E1468. doi: 10.1097/BRS.0b013e31826ca2a8 [DOI] [PubMed] [Google Scholar]
  • 62.Kim JW, Park SW, Kim YB, Ko MJ. The effect of postoperative use of teriparatide reducing screw loosening in osteoporotic patients. J Korean Neurosurg Soc. 2018;61(4):494-502. doi: 10.3340/jkns.2017.0216 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Kaliya-Perumal AK, Lu ML, Luo CA, et al. Retrospective radiological outcome analysis following teriparatide use in elderly patients undergoing multilevel instrumented lumbar fusion surgery. Medicine (Baltim). 2017;96(5):e5996. doi: 10.1097/MD.0000000000005996 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Ohtori S, Inoue G, Orita S, et al. Comparison of teriparatide and bisphosphonate treatment to reduce pedicle screw loosening after lumbar spinal fusion surgery in postmenopausal women with osteoporosis from a bone quality perspective. Spine. 2013;38(8):E487-E492. doi: 10.1097/BRS.0b013e31828826dd [DOI] [PubMed] [Google Scholar]
  • 65.Ebata S, Takahashi J, Hasegawa T, et al. Role of weekly teriparatide administration in osseous union enhancement within six months after posterior or transforaminal lumbar interbody fusion for osteoporosis-associated lumbar degenerative disorders: a multicenter, prospective randomized study. J Bone Joint Surg Am. 2017;99(5):365-372. doi: 10.2106/JBJS.16.00230 [DOI] [PubMed] [Google Scholar]
  • 66.Cho PG, Ji GY, Shin DA, Ha Y, Yoon DH, Kim KN. An effect comparison of teriparatide and bisphosphonate on posterior lumbar interbody fusion in patients with osteoporosis: a prospective cohort study and preliminary data. Eur Spine J. 2017;26(3):691-697. doi: 10.1007/s00586-015-4342-y [DOI] [PubMed] [Google Scholar]
  • 67.Inoue G, Ueno M, Nakazawa T, et al. Teriparatide increases the insertional torque of pedicle screws during fusion surgery in patients with postmenopausal osteoporosis. J Neurosurg Spine. 2014;21(3):425-431. doi: 10.3171/2014.5.SPINE13656 [DOI] [PubMed] [Google Scholar]
  • 68.Jespersen AB, Andresen ADK, Jacobsen MK, Andersen MO, Carreon LY. Does systemic administration of parathyroid hormone after noninstrumented spinal fusion surgery improve fusion rates and fusion mass in elderly patients compared to placebo in patients with degenerative lumbar spondylolisthesis? Spine. 2019;44(3):157-162. doi: 10.1097/BRS.0000000000002791 [DOI] [PubMed] [Google Scholar]
  • 69.Oba H, Takahashi J, Yokomichi H, et al. Weekly teriparatide versus bisphosphonate for bone union during 6 Months after multi-level lumbar interbody fusion for osteoporotic patients: a multicenter, prospective, randomized study. Spine. 2020;45(13):863-871. doi: 10.1097/BRS.0000000000003426 [DOI] [PubMed] [Google Scholar]
  • 70.Cosman F, Miller PD, Williams GC, et al. Eighteen months of treatment with subcutaneous abaloparatide followed by 6 Months of treatment with alendronate in postmenopausal women with osteoporosis: results of the ACTIVExtend trial. Mayo Clin Proc. 2017;92(2):200-210. doi: 10.1016/j.mayocp.2016.10.009 [DOI] [PubMed] [Google Scholar]
  • 71.Dhaliwal R, Hans D, Hattersley G, et al. Abaloparatide in postmenopausal women with osteoporosis and type 2 diabetes: a post hoc analysis of the active study. JBMR Plus. 2020;4(4):e10346. doi: 10.1002/jbm4.10346 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Miller PD, Hattersley G, Lau E, et al. Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: results from the ACTIVE phase 3 trial. Bone. 2019;120:137-140. doi: 10.1016/j.bone.2018.10.015 [DOI] [PubMed] [Google Scholar]
  • 73.Miller PD, Hattersley G, Riis BJ, et al. Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial. JAMA. 2016;316(7):722-733. doi: 10.1001/jama.2016.11136 [DOI] [PubMed] [Google Scholar]
  • 74.Kang T, Park SY, Hong SH, Lee JH, Lee SH, Park JH. Bone union after spinal fusion surgery using local bone in long-term bisphosphonate users: a prospective comparative study. Arch Osteoporosis. 2019;14(1):74. doi: 10.1007/s11657-019-0628-8 [DOI] [PubMed] [Google Scholar]
  • 75.Nagahama K, Kanayama M, Togawa D, Hashimoto T, Minami A. Does alendronate disturb the healing process of posterior lumbar interbody fusion? A prospective randomized trial. J Neurosurg Spine. 2011;14(4):500-507. doi: 10.3171/2010.11.SPINE10245 [DOI] [PubMed] [Google Scholar]
  • 76.Kim SM, Rhee W, Ha S, Lim JH, Jang IT. Influence of alendronate and endplate degeneration to single level posterior lumbar spinal interbody fusion. Korean J Spine. 2014;11(4):221-226. doi: 10.14245/kjs.2014.11.4.221 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Liu B, Liu X, Chen Y, et al. Clinical effect observation of intravenous application of zoledronic acid in patients with cervical spondylosis and osteoporosis after anterior cervical discectomy and fusion: a randomized controlled study. J Orthop Surg. 2019;27(2). [DOI] [PubMed] [Google Scholar]
  • 78.Ding Q, Chen J, Fan J, Li Q, Yin G, Yu L. Effect of zoledronic acid on lumbar spinal fusion in osteoporotic patients. Eur Spine J. 2017;26(11):2969-2977. doi: 10.1007/s00586-017-5286-1 [DOI] [PubMed] [Google Scholar]
  • 79.Chen F, Dai Z, Kang Y, Lv G, Keller ET, Jiang Y. Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion. Osteoporos Int. 2016;27(4):1469-1476. doi: 10.1007/s00198-015-3398-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Park YS, Kim HS, Baek SW, Kong DY, Ryu JA. The effect of zoledronic acid on the volume of the fusion-mass in lumbar spinal fusion. Clin Orthop Surg. 2013;5(4):292-297. doi: 10.4055/cios.2013.5.4.292 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Li C, Wang HR, Li XL, Zhou XG, Dong J. The relation between zoledronic acid infusion and interbody fusion in patients undergoing transforaminal lumbar interbody fusion surgery. Acta Neurochir. 2012;154(4):731-738. doi: 10.1007/s00701-012-1283-7 [DOI] [PubMed] [Google Scholar]
  • 82.Tu CW, Huang KF, Hsu HT, Li HY, Yang SS, Chen YC. Zoledronic acid infusion for lumbar interbody fusion in osteoporosis. J Surg Res. 2014;192(1):112-116. doi: 10.1016/j.jss.2014.05.034 [DOI] [PubMed] [Google Scholar]
  • 83.Maruo K, Tachibana T, Arizumi F, Kusuyama K, Kishima K, Yoshiya S. Effect of teriparatide on subsequent vertebral fractures after instrumented fusion surgery for osteoporotic vertebral fractures with neurological deficits. Asian Spine J. 2019;13(2):283-289. doi: 10.31616/asj.2018.0098 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Ide M, Yamada K, Kaneko K, et al. Combined teriparatide and denosumab therapy accelerates spinal fusion following posterior lumbar interbody fusion. Orthop Traumatol Surg Res. 2018;104(7):1043-1048. doi: 10.1016/j.otsr.2018.07.015 [DOI] [PubMed] [Google Scholar]
  • 85.Cummings SR, San Martin J, McClung MR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361(8):756-765. doi: 10.1056/NEJMoa0809493 [DOI] [PubMed] [Google Scholar]
  • 86.Cosman F, Crittenden DB, Adachi JD, et al. Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med. 2016;375(16):1532-1543. doi: 10.1056/NEJMoa1607948 [DOI] [PubMed] [Google Scholar]
  • 87.Bandeira L, Lewiecki EM, Bilezikian JP. Romosozumab for the treatment of osteoporosis. Expet Opin Biol Ther. 2017;17(2):255-263. doi: 10.1080/14712598.2017.1280455 [DOI] [PubMed] [Google Scholar]
  • 88.Mikula AL, Lakomkin N, Hamouda AM, et al. Change in spinal bone mineral density as estimated by Hounsfield units following osteoporosis treatment with romosozumab, teriparatide, denosumab, and alendronate: an analysis of 318 patients. J Neurosurg Spine. 2024;41(3):309-315. doi: 10.3171/2024.4.SPINE2424 [DOI] [PubMed] [Google Scholar]
  • 89.Ravindra VM, Godzik J, Dailey AT, et al. Vitamin D levels and 1-year fusion outcomes in elective spine surgery: a prospective observational study. Spine. 2015;40(19):1536-1541. doi: 10.1097/BRS.0000000000001041 [DOI] [PubMed] [Google Scholar]
  • 90.Stoker GE, Buchowski JM, Bridwell KH, Lenke LG, Riew KD, Zebala LP. Preoperative vitamin D status of adults undergoing surgical spinal fusion. Spine. 2013;38(6):507-515. doi: 10.1097/BRS.0b013e3182739ad1 [DOI] [PubMed] [Google Scholar]
  • 91.Kim TH, Yoon JY, Lee BH, et al. Changes in vitamin D status after surgery in female patients with lumbar spinal stenosis and its clinical significance. Spine. 2012;37(21):E1326-E1330. doi: 10.1097/BRS.0b013e318268ff05 [DOI] [PubMed] [Google Scholar]
  • 92.Skrobot W, Liedtke E, Krasowska K, et al. Early rehabilitation program and vitamin D supplementation improves sensitivity of balance and the postural control in patients after posterior lumbar interbody fusion: a randomized trial. Nutrients. 2019;11(9). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Ravindra VM, Guan J, Holland CM, et al. Vitamin D status in cervical spondylotic myelopathy: comparison of fusion rates and patient outcome measures. J Neurosurg Sci. 2019;63(1):36-41. doi: 10.23736/S0390-5616.16.03846-7 [DOI] [PubMed] [Google Scholar]
  • 94.Krasowska K, Skrobot W, Liedtke E, et al. The preoperative supplementation with vitamin D attenuated pain intensity and reduced the level of pro-inflammatory markers in patients after posterior lumbar interbody fusion. Front Pharmacol. 2019;10:527. doi: 10.3389/fphar.2019.00527 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Donnally CJ, 3rd, Sheu JI, Bondar KJ, et al. Is there a correlation between preoperative or postoperative vitamin D levels with pseudarthrosis, hardware failure, and revisions after lumbar spine fusion? World Neurosurg. 2019;130:e431-e437. doi: 10.1016/j.wneu.2019.06.109 [DOI] [PubMed] [Google Scholar]
  • 96.Waikakul S. Serum 25-hydroxy-calciferol level and failed back surgery syndrome. J Orthop Surg. 2012;20(1):18-22. doi: 10.1177/230949901202000104 [DOI] [PubMed] [Google Scholar]
  • 97.Tandon V, Franke J, Kalidindi KKV. Advancements in osteoporotic spine fixation. J Clin Orthop Trauma. 2020;11(5):778-785. doi: 10.1016/j.jcot.2020.06.028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Kanno H, Onoda Y, Hashimoto K, Aizawa T, Ozawa H. Innovation of surgical techniques for screw fixation in patients with osteoporotic spine. J Clin Med. 2022;11(9):2577. doi: 10.3390/jcm11092577 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Joaquim AF, Patel AA. Diagnosis, risk factors, and management of sacral and pelvic fractures after instrumented lumbar fusions: a systematic review. Global Spine J. 2019;9(5):540-544. doi: 10.1177/2192568218779986 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Marie-Hardy L, Pascal-Moussellard H, Barnaba A, Bonaccorsi R, Scemama C. Screw loosening in posterior spine fusion: prevalence and risk factors. Global Spine J. 2020;10(5):598-602. doi: 10.1177/2192568219864341 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Wilde GE, Miller TT, Schneider R, Girardi FP. Sacral fractures after lumbosacral fusion: a characteristic fracture pattern. AJR Am J Roentgenol. 2011;197(1):184-188. doi: 10.2214/AJR.10.5902 [DOI] [PubMed] [Google Scholar]
  • 102.Kebaish KM, Martin CT, O'Brien JR, LaMotta IE, Voros GD, Belkoff SM. Use of vertebroplasty to prevent proximal junctional fractures in adult deformity surgery: a biomechanical cadaveric study. Spine J. 2013;13(12):1897-1903. doi: 10.1016/j.spinee.2013.06.039 [DOI] [PubMed] [Google Scholar]
  • 103.Martin CT, Skolasky RL, Mohamed AS, Kebaish KM. Preliminary results of the effect of prophylactic vertebroplasty on the incidence of proximal junctional complications after posterior spinal fusion to the low thoracic spine. Spine Deform. 2013;1(2):132-138. doi: 10.1016/j.jspd.2013.01.005 [DOI] [PubMed] [Google Scholar]
  • 104.Theologis AA, Burch S. Prevention of acute proximal junctional fractures after long thoracolumbar posterior fusions for adult spinal deformity using 2-level cement augmentation at the upper instrumented vertebra and the vertebra 1 level proximal to the upper instrumented vertebra. Spine. 2015;40(19):1516-1526. doi: 10.1097/BRS.0000000000001043 [DOI] [PubMed] [Google Scholar]
  • 105.Raman T, Miller E, Martin CT, Kebaish KM. The effect of prophylactic vertebroplasty on the incidence of proximal junctional kyphosis and proximal junctional failure following posterior spinal fusion in adult spinal deformity: a 5-year follow-up study. Spine J. 2017;17(10):1489-1498. doi: 10.1016/j.spinee.2017.05.017 [DOI] [PubMed] [Google Scholar]
  • 106.Uchida K, Kobayashi S, Nakajima H, et al. Anterior expandable strut cage replacement for osteoporotic thoracolumbar vertebral collapse. J Neurosurg Spine. 2006;4(6):454-462. doi: 10.3171/spi.2006.4.6.454 [DOI] [PubMed] [Google Scholar]
  • 107.Suk SI, Kim JH, Lee SM, Chung ER, Lee JH. Anterior-posterior surgery versus posterior closing wedge osteotomy in posttraumatic kyphosis with neurologic compromised osteoporotic fracture. Spine. 2003;28(18):2170-2175. doi: 10.1097/01.BRS.0000090889.45158.5A [DOI] [PubMed] [Google Scholar]

Articles from Global Spine Journal are provided here courtesy of SAGE Publications

RESOURCES